Our Story Samsara BioCapital was founded after years of working in the medical field and investment industry. Our goal is to help entrepreneurs turn their own ideas and visions into successful companies with fundraising and networking guidance. As a results-driven organization, we are constantly looking for ambitious and visionary partners with the drive and flexibility […]
Investment Type: Venture Capital
Portfolio 3
| Date | Name | Website | Total Raised | Location |
| 11.07.2023 | @Septerna_... | septerna.c... | $290M | United Sta... |
| 10.07.2023 | SpyGlass P... | spyglassph... | $90M | United Sta... |
| 19.07.2022 | Delfi Diag... | delfidiagn... | $325M | United Sta... |
Mentions in press and media 5
| Date | Title | Description | Source |
| 14.11.2023 | Autobahn Labs Announces Key Licensing Milestones in Alliance... | I’m thrilled to see our early partnerships bearing fruit. The two startups, in which we have already... | einpresswi... |
| 08.08.2023 | Autobahn Labs Appoints Chief Executive Officer | Brendan O'Leary - CEO, Autobahn Labs Experienced Life Sciences Executive and Venture Capitalist Dr.... | einpresswi... |
| 09.05.2023 | Autobahn Labs Announces Strategic Collaboration with the Sal... | New Collaboration Adds to Autobahn Labs’ Transformative Biotech Incubator Model in California and th... | einpresswi... |
| 07.06.2022 | ImmunOs Therapeutics raises $74 Million to fund clinical tri... | ImmunOs Therapeutics has identified specific human leukocyte antigen (HLA) molecules known to acti... | startuptic... |
| 06.04.2021 | Mineralys Therapeutics Closes $40 Million Series A Funding | Aldosterone has been implicated as an underlying cause of hypertension in upwards of 30 percent of a... | catalyspac... |